Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-12-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Whole-body Vibration on Balance Control, Postural Stability and Mobility After Thermal Burn Injuries.
NCT04500314
Whole-body Vibration Without Visual Feedback on Postural Steadiness in Unilateral Trans-femoral Traumatic Amputees
NCT06284733
Acute Effect of Whole Body Vibration on Reaction Speed and Proprioception
NCT06172244
Impact of Whole-body Vibration Training on Flexibility, Muscular Activity and Quality of Life After Lower Extremity Thermal Burn Injury
NCT06787716
Effect of Upper Limb Ergometer on the AIP in Post Menopausal Obese Women.
NCT04676074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
WBV is a mechanical stimulation characterized by oscillatory motion supplied from a platform to the entire body. The current devices employ two distinct systems: (a) a vertical vibration, in which the entire plate oscillates uniformly up and down with only a vertical translation; and (b) reciprocating vertical displacements on the left and right sides of a fulcrum, which increases the lateral accelerations. WBV training includes biomechanical characteristics such as body position, amplitude, frequency, magnitude, and duration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (WBV Group)
A vibrating platform (WBV) will be used in this study with 6 training exercises for 4 minutes, 2 times /week for 6 weeks. Feet should be parallel at shoulder width apart and knees hold constant. WBV sessions were conducted from low to medium-vibration mode
Whole body Vibration
A vibrating platform (WBV) will be used in this study with 6 training exercises for 4 minutes, 2 times /week for 6 weeks. Feet should be parallel at shoulder width apart and knees hold constant. WBV sessions were conducted from low to medium-vibration mode
Group B (Sham WBV Group)
They will receive the same intervention while the device turned off for 4 minutes, 2 session/ week for 6 weeks.
Sham Whole body vibration
They will receive the same intervention while the device turned off for 4 minutes, 2 times /week for 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole body Vibration
A vibrating platform (WBV) will be used in this study with 6 training exercises for 4 minutes, 2 times /week for 6 weeks. Feet should be parallel at shoulder width apart and knees hold constant. WBV sessions were conducted from low to medium-vibration mode
Sham Whole body vibration
They will receive the same intervention while the device turned off for 4 minutes, 2 times /week for 6 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 30
* Aged from 18 to 25 years old
Exclusion Criteria
* Musculoskeletal disorders
* History of spinal surgery
* Epilepsy
* Medications that could affect the musculoskeletal system
* Performing regular exercise of more than 3 times a week
* Metal plates in the body
* Ligament sprain
* Medical history such as cardiovascular disease, or diabetes mellitus
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nesma Morgan Allam
Assistant Professor of physical therapy for surgery, Faculty of physical therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hadaya M Eladl, PhD
Role: STUDY_DIRECTOR
Assisstant professor of physical therapy for surgery, Faculty of physical therapy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nesma Morgan Allam
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB Approval No. 2023-125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.